Showing results (1-10 of 276) with videos related to
Sort By:
Pageof 28
Current Pharmaceutical Design|July 9, 2013
Cannabinoids and schizophrenia: therapeutic prospectsP J Robson, G W Guy, V Di MarzoBiochimica Et Biophysica Acta|June 19, 1998
'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceV Di MarzoLife Sciences|August 26, 1999
Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulatorsV Di MarzoReviews of Physiology, Biochemistry and Pharmacology|May 16, 2008
Endocannabinoids: synthesis and degradationV Di MarzoBiochemistry. Biokhimiia|April 4, 1998
2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metaboliteV Di MarzoNeurogastroenterology and Motility|April 13, 2011
Gut feelings about the endocannabinoid systemV Di Marzo, F PiscitelliTrends in Neurosciences|September 28, 2000
New perspectives on enigmatic vanilloid receptorsA Szallasi, V Di MarzoJournal of Endocrinological Investigation|June 6, 2006
Endocannabinoid synthesis and degradation, and their regulation in the framework of energy balanceI Matias, V Di MarzoJournal of Lipid Mediators|March 1, 1993
Dopamine D2 receptor signaling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2D Piomelli, V Di MarzoPageof 28